Português 
Inglês 
Espanhol 
2 min de leitura 
1 comentário 
Expansion of Pharmaceutical Production, Valued at R$ 500 Million, Consolidates Minas Gerais as a Global Reference in the Health Sector
The Danish pharmaceutical company Novo Nordisk announced a new investment of R$ 500 million in Montes Claros, Minas Gerais. The amount will be allocated to the installation of a production line aimed at enzymes essential for drug manufacturing. This expansion is strategic to meet the growing global demand for treatments of chronic diseases such as diabetes and obesity, according to the EM website.
Among the highlights are the enzymes enteropeptidase and ALP, crucial in the production of insulin and GLP-1 analogs, such as Ozempic and Wegovy. Montes Claros is the sole supplier of these components for Novo Nordisk’s matrix in Denmark, consolidating its position as a global hub in the sector.
Investment Details
The project, with construction starting in January 2025, will create 400 indirect jobs during construction and 40 direct jobs in operation. Production is expected to begin in 2027, tripling current capacity.
-
Brazilian city gains industrial hub for 85 companies that is equivalent to 55 football fields.
-
Peugeot and Citroën factory in Argentina cuts production by half and opens a layoff program for more than 2,000 employees after Brazil drastically reduced purchases of Argentine vehicles.
-
A Brazilian city gains a factory worth R$ 300 million with the capacity to process 200 thousand tons of wheat per year, a mill of 660 tons/day, silos for 42 thousand tons, and an industrial area of 276 thousand m².
-
Havan will leave the shopping mall in Blumenau to inaugurate something that the chain has never done before: a megastore in half-timbered style in the Historic Center of the city, which is expected to be completed in May and change the landscape of local retail.
Global Relevance
- The Montes Claros unit is responsible for 25% of Novo Nordisk’s global insulin production.
- It represents 12% of global consumption and 25% of Brazilian pharmaceutical exports.
- More than 70% of the insulin supplied to SUS is produced by the company, serving 4.3 million Brazilians per year.
Sustainability and Innovation
In addition to the new investment, the company had already announced in 2023 a contribution of R$ 864 million for the modernization of its facilities. At the same time, in partnership with Elétron Energy, Novo Nordisk is investing R$ 245 million in the construction of a solar park, with a capacity to generate 90 MWh. The project will become operational in 2025, ensuring that all the energy used by the unit comes from renewable sources.
Regional Impacts and Government Support
The governor of Minas Gerais, Romeu Zema, highlighted the role of the investment in transforming Montes Claros into one of the main pharmaceutical hubs in the country. According to him, the state is on track to reach half a trillion in private investments and create one million jobs by 2025.
Leadership Statements:
- Reinaldo Costa, Vice President of Novo Nordisk: “This investment reaffirms our commitment to Brazil and Minas Gerais.”
- Fernando Passalio, Secretary of Economic Development: “Montes Claros becomes a reference in innovation and sustainability, reinforcing the role of Minas Gerais in the energy transition.”
Minas Gerais also seeks to diversify its economy, reducing dependence on the mineral sector. In addition to the pharmaceutical industry, the state stands out in solar energy generation, representing 20% of national capacity, and attracts investments in sectors such as appliances and automotive.
o que nova nordisk está fazendo e um verdadeiro absurdo , no Brasil nunca faltou insulina nph e regular de 10 ml , há mais ou menos essa grande indústria simplesmente não está fabricando essas insulina que são super necessária para sobrevivência do diabeticos , tornado a vida do diabético um verdadeiro drama na sua saúde , agradecemos desde já que a nova nodisk resolva a falta de insulina nph e regular , desde já agradeço em nome do povo diabético do Brasil ,principalmente os menos favorecido!!!